• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

度普利尤单抗治疗斑秃和特应性皮炎儿科患者的毛发再色素沉着和再生:一例报告

Hair repigmentation and regrowth in a dupilumab-treated paediatric patient with alopecia areata and atopic dermatitis: a case report.

作者信息

Yan Xin, Tayier Munire, Cheang Sin Tong, Liao Zhongmin, Dong Yi, Yang Yifeng, Ye Yanting, Zhang Xingqi

机构信息

Department of Dermatology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Department of Dermatology, The First Affiliated Hospital, Sun Yat-sen University, No.58 Zhongshan Er Road, Guangzhou, Guangdong Province 510080, China.

出版信息

Ther Adv Chronic Dis. 2023 Aug 4;14:20406223231191049. doi: 10.1177/20406223231191049. eCollection 2023.

DOI:10.1177/20406223231191049
PMID:37546700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10403978/
Abstract

Alopecia areata (AA) is a chronic inflammatory disease mainly involving Th1 immunoreaction, but Th2 is also involved. A 9-year-old girl presented to our clinic with severe alopecia for 2 months and pruritus-related rashes for 8 years. She was diagnosed with AA and atopic dermatitis (AD), and the Severity of Alopecia Tool (SALT) score was 98. She used a 0.05% halometasone cream (occlusive dressing) topically applied overnight (6 days weekly) for 10 months. After 2 months of treatment, she had regrowth of both black and white hair. However, relapse occurred and she gradually lost all black terminal hair, but white terminal hair remained, with a SALT score of 70. Continuous topical occlusion resulted in white hair regrowth with a SALT score of 20 at the end of month 10. Dupilumab was initially prescribed as a 600-mg subcutaneous injection and maintained at 300 mg every 4 weeks thereafter. Hair repigmentation (10% of whole hair density) started, with black hair shaft appearing at the proximal end in parietal-occipital and occipital areas after three injections at week 12 of dupilumab therapy, with a SALT score of 10. After seven injections at week 28, the percentage of black hair shaft reached up to 90, and she regained her black hair and the pigmented section of hair shaft continued to grow longer at the rate of normal hair growth. Nevertheless, 4 months after termination of dupilumab therapy, the black terminal hair began to fall off, and white vellus hair gradually regrew on the scalp, with a SALT score of 80. Dupilumab induces hair regrowth and repigmentation of white terminal hair without disturbing the anagen phase of hair follicles. Therefore, melanocytes in AA may be a potential target of Th2-related factors. Persistent regrowth of white hair may be used as a signal of Th2 dominance in AA management.

摘要

斑秃(AA)是一种主要涉及Th1免疫反应的慢性炎症性疾病,但Th2也参与其中。一名9岁女孩因严重脱发2个月、伴有瘙痒相关皮疹8年前来我院就诊。她被诊断为斑秃和特应性皮炎(AD),脱发严重程度工具(SALT)评分98分。她外用0.05%卤米松乳膏(封包),每周6天,每晚一次,持续10个月。治疗2个月后,她的黑白头发均有再生。然而,病情复发,她逐渐失去了所有黑色终毛,但白色终毛仍在,SALT评分为70分。持续外用封包治疗使白色头发再生,在第10个月末SALT评分为20分。最初使用度普利尤单抗600mg皮下注射,此后每4周维持300mg。毛发色素沉着(占全发密度的10%)开始出现,在度普利尤单抗治疗第12周注射3次后,顶枕部和枕部近端出现黑色毛干,SALT评分为10分。在第28周注射7次后,黑色毛干的比例达到90%,她重新长出了黑发,毛干的色素沉着部分继续以正常头发生长速度生长。然而,度普利尤单抗治疗终止4个月后,黑色终毛开始脱落,头皮上逐渐重新长出白色毳毛,SALT评分为80分。度普利尤单抗可诱导白发再生和色素沉着,且不干扰毛囊的生长期。因此,斑秃中的黑素细胞可能是Th2相关因子的潜在靶点。白发持续再生可能作为斑秃治疗中Th2占主导地位的一个信号。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a05/10403978/a177cae71f28/10.1177_20406223231191049-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a05/10403978/104bc101a6ab/10.1177_20406223231191049-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a05/10403978/9e25f02566d5/10.1177_20406223231191049-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a05/10403978/7e661348e0c9/10.1177_20406223231191049-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a05/10403978/a177cae71f28/10.1177_20406223231191049-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a05/10403978/104bc101a6ab/10.1177_20406223231191049-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a05/10403978/9e25f02566d5/10.1177_20406223231191049-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a05/10403978/7e661348e0c9/10.1177_20406223231191049-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a05/10403978/a177cae71f28/10.1177_20406223231191049-fig4.jpg

相似文献

1
Hair repigmentation and regrowth in a dupilumab-treated paediatric patient with alopecia areata and atopic dermatitis: a case report.度普利尤单抗治疗斑秃和特应性皮炎儿科患者的毛发再色素沉着和再生:一例报告
Ther Adv Chronic Dis. 2023 Aug 4;14:20406223231191049. doi: 10.1177/20406223231191049. eCollection 2023.
2
Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study.度普利尤单抗可诱导儿童斑秃毛发再生:一项真实世界、单中心观察性研究。
Arch Dermatol Res. 2024 Jul 23;316(7):487. doi: 10.1007/s00403-024-03225-4.
3
Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients.斑秃患者度普利尤单抗(抗 IL-4Rα)的 2a 期随机临床试验。
Allergy. 2022 Mar;77(3):897-906. doi: 10.1111/all.15071. Epub 2021 Sep 6.
4
Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children.病例报告:度普利尤单抗和巴瑞替尼序贯疗法治疗儿童伴有特应性皮炎的重症斑秃。
Front Immunol. 2024 Jun 6;15:1395288. doi: 10.3389/fimmu.2024.1395288. eCollection 2024.
5
Long-Term Efficacy of Dupilumab in Alopecia Areata.斑秃患者使用度普利尤单抗的长期疗效。
Am J Case Rep. 2022 Jun 21;23:e936488. doi: 10.12659/AJCR.936488.
6
Full scalp hair regrowth in a 4-year-old girl with alopecia areata and atopic dermatitis treated with dupilumab.用度普利尤单抗治疗的一名患有斑秃和特应性皮炎的4岁女孩头皮毛发完全再生。
JAAD Case Rep. 2020 Oct 15;6(12):1286-1287. doi: 10.1016/j.jdcr.2020.10.010. eCollection 2020 Dec.
7
Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata.在治疗斑秃时,头皮生物标志物支持白细胞介素-35 通路在发病机制中的作用。
Allergy. 2023 Apr;78(4):1047-1059. doi: 10.1111/all.15561. Epub 2022 Nov 5.
8
Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib.病例报告:度普利尤单抗治疗对巴瑞替尼耐药的4岁斑秃患者。
Front Med (Lausanne). 2023 Oct 9;10:1253795. doi: 10.3389/fmed.2023.1253795. eCollection 2023.
9
Dupliumab therapy for alopecia areata: a case series and review of the literature.度普利尤单抗治疗斑秃:病例系列及文献综述
J Dermatolog Treat. 2024 Dec;35(1):2312245. doi: 10.1080/09546634.2024.2312245. Epub 2024 Feb 11.
10
[Hair growth with dupilumab in alopecia areata universalis and atopic dermatitis].[度普利尤单抗治疗泛发性斑秃和特应性皮炎时的毛发生长]
Dermatologie (Heidelb). 2022 Jul;73(7):556-559. doi: 10.1007/s00105-021-04898-y. Epub 2021 Oct 5.

引用本文的文献

1
Dupilumab and Alopecia Areata: A Possible Combined or Disturbance Therapy? A Review of The Literature.度普利尤单抗与斑秃:一种可能的联合治疗或干扰治疗?文献综述
Dermatol Pract Concept. 2024 Oct 30;14(4):e2024270. doi: 10.5826/dpc.1404a270.
2
Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study.度普利尤单抗可诱导儿童斑秃毛发再生:一项真实世界、单中心观察性研究。
Arch Dermatol Res. 2024 Jul 23;316(7):487. doi: 10.1007/s00403-024-03225-4.